Investigation of Fibrogen, Inc.
FibroGen, Inc. (FGEN) Misstated the Efficacy of its Drug Roxadustat On November 8, 2019, ...
READ MOREInvestigation of Amdocs Limited
Amdocs Limited (DOX) Misstated its Financials Amdocs conducted its 2021 Annual General Meeting ("AGM") ...
READ MOREInvestigation of 3D Systems Corp.
3D Systems Corp. (DDD) Lacked Proper Internal Controls Over Financial Reporting Throughout the class ...
READ MOREInvestigation of CytoDyn Inc.
CytoDyn Inc. (CYDY) Misled Shareholders About the Viability of its Drug for the Treatment of ...
READ MOREInvestigation of Ebang International Holdings Inc.
Ebang International Holdings Inc. (EBON) Misled Investors Regarding its Business Plan During the class period, ...
READ MOREInvestigation of Canoo, Inc.
Canoo Inc. (GOEV) Misled Investors Regarding its Business Model Canoo Holdings Ltd., an electric ...
READ MOREInvestigation of OneSpan Inc.
OneSpan Inc. (OSPN) Overstated its Revenue OneSpan Inc. may have made false and misleading ...
READ MOREInvestigation of Kadmon Holdings, Inc.
Kadmon Holdings, Inc. (KDMN) Misled Investors Regarding its New Drug Submission for its Lead Drug ...
READ MOREInvestigation of Plug Power, Inc.
Plug Power, Inc. (PLUG) Misled Shareholders Regarding its Internal Controls Over Financial Reporting On November ...
READ MOREInvestigation of Workhorse Group, Inc.
Workhorse Group, Inc. (WKHS) Misled Shareholders About Its Ability to Obtain a Delivery Vehicle Contract ...
READ MOREHow can we help you?
CONTACT US TODAY | 1 800 350 6003 or [email protected]